Image Credit: STAT News
STAT+: Pharmalittle: We’re reading about FDA losing key personnel, a ‘colossal’ Pfizer tax dodge, and more
Both deputy directors at the key FDA center that oversees regulation of cancer drugs plan on leaving the agency